Keyphrases
COVID-19
87%
SARS-CoV-2 Infection
25%
Contact Tracing
16%
Recombinant
15%
Viral
15%
Viral Replication
15%
Host Response
15%
Human Lung Tissue
15%
Quantitative PCR
14%
University Population
13%
Lloviu Virus
13%
Viral Host
13%
Urban Universities
13%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
13%
African Green Monkey
13%
Clinical Disease
13%
Persistent Infection
13%
SARS-CoV-2 Transmission
12%
Rapid Diagnostic Test
11%
Healthcare Workers
11%
University Campus
10%
Viral Genome
10%
Genomic Surveillance
9%
Omicron Variant
9%
Vaccination
9%
Vaccine Impact
9%
Filovirus
8%
Fatal Outcome
8%
Fetal Lung
8%
Xenograft
8%
Genomic Analysis
8%
Macrophages
7%
Transmission Dynamics
7%
Medical Center
7%
Recombinant Virus
6%
Public Health Mandates
6%
Tissue Protection
6%
MAb114
6%
Anterior Nares
6%
BinaxNOW
6%
Unstable Housing
6%
Close Contact
6%
Soccer Clubs
6%
Major League Soccer
6%
Sample Quality
6%
Nipah Virus
6%
Pfizer-BioNTech
6%
Cell Culture Model
6%
Humanized Mice
6%
Heat Inactivation
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
55%
Infection
38%
Virus
20%
Immune Response
16%
Viral Replication
14%
RNA Sequence
13%
Chlorocebus Aethiops
13%
Ebola Virus
13%
Infectious Agent
12%
Macrophage
9%
Ribonucleic Acid
9%
Replication
9%
Filovirus
8%
Cell Culture
8%
Omicron Coronavirus Variant
8%
COVID-19
7%
Recombinant Virus
6%
NKG2D
6%
Protein Splicing
6%
Dynamics
6%
Humanized Mouse
6%
2,5-Dimethoxy-4-iodoamphetamine
6%
Immunocompromised Patient
6%
Emerging Viruses
6%
Hendra Virus
6%
Human Immunodeficiency Virus
6%
Nipah virus
6%
Lassa Virus
6%
RNA Virus
5%
Virus Genome
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
32%
COVID-19
23%
Lung
14%
Health Care Personnel
12%
Persistent Infection
9%
Cohort Analysis
8%
Contact Examination
8%
Public Health
8%
Omicron Coronavirus Variant
8%
Macrophage
7%
Culture Conversion
6%
Genomic Epidemiology
6%
Reinfection
6%
Virus Recombinant
6%
Prospective Cohort Study
6%
Immunocompromised Patient
6%
Cell Culture
6%
Human Immunodeficiency Virus
6%
Diagnostic Testing
6%
Reverse Transcription Polymerase Chain Reaction
6%
Virus
6%